Zu, C.; Xu, Y.; Wang, Y.; Zhang, M.; Zhao, H.; Fang, X.; Huang, H.; Hu, Y.
Cytomegalovirus Retinitis and Retinal Detachment following Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory Multiple Myeloma. Curr. Oncol. 2022, 29, 490-496.
https://doi.org/10.3390/curroncol29020044
AMA Style
Zu C, Xu Y, Wang Y, Zhang M, Zhao H, Fang X, Huang H, Hu Y.
Cytomegalovirus Retinitis and Retinal Detachment following Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory Multiple Myeloma. Current Oncology. 2022; 29(2):490-496.
https://doi.org/10.3390/curroncol29020044
Chicago/Turabian Style
Zu, Cheng, Yufeng Xu, Yiyun Wang, Mingming Zhang, Houli Zhao, Xiaoyun Fang, He Huang, and Yongxian Hu.
2022. "Cytomegalovirus Retinitis and Retinal Detachment following Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory Multiple Myeloma" Current Oncology 29, no. 2: 490-496.
https://doi.org/10.3390/curroncol29020044
APA Style
Zu, C., Xu, Y., Wang, Y., Zhang, M., Zhao, H., Fang, X., Huang, H., & Hu, Y.
(2022). Cytomegalovirus Retinitis and Retinal Detachment following Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory Multiple Myeloma. Current Oncology, 29(2), 490-496.
https://doi.org/10.3390/curroncol29020044
